Zynlonta 10 mg lyophilized powder for injection Images
Generic Name: loncastuximab tesirine
This medication has been identified as Zynlonta 10 mg lyophilized powder for injection and is used for Diffuse Large B-Cell Lymphoma. It belongs to the drug class miscellaneous antineoplastics and is not a controlled substance.
Images of medication
Zynlonta
- Generic Name
- loncastuximab tesirine
- Strength
- 10 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- ADC Therapeutics SA
- National Drug Code (NDC)
- 79952-0110
See also:
More about Zynlonta (loncastuximab tesirine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.